[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"rotator-cuff-tendinopathy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:rotator-cuff-tendinopathy":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,49,78,104,129,151,189,215],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100631555","notch-vs-midpoint-suprascapular-nerve-prf-for-chronic-shoulder-pain-100631555",false,"NCT07502209","Notch vs Midpoint Suprascapular Nerve PRF for Chronic Shoulder Pain","Comparison of Suprascapular Notch and Midpoint Approaches in Pulsed Radiofrequency Treatment of the Suprascapular Nerve on Pain and Function in Patients With Chronic Shoulder Pain","SUPRA-PRF","Inclusion Criteria:\n\n* Patients aged between 40 and 80 years\n* Patients with chronic shoulder pain lasting longer than 3 months\n* Patients diagnosed with rotator cuff-related shoulder pain\n* Patients who show at least 50% pain reduction after diagnostic suprascapular nerve block\n* Patients who provide written informed consent\n\nExclusion Criteria:\n\n* Adhesive capsulitis\n* Previous shoulder surgery\n* Full-thickness rotator cuff tear\n* Neurological disorders affecting the shoulder\n* Pacemaker\n* Coagulopathy or anticoagulant therapy contraindicating intervention\n* Infection at the injection site\n* Severe systemic disease\n* Pregnancy\n* Inability to comply with study protocol","ALL","40 Years","80 Years",{"count":21,"type":22},32,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study aims to compare the effects of pulsed radiofrequency (PRF) treatment of the suprascapular nerve using suprascapular notch and midpoint approaches on pain, shoulder function, and muscle strength in patients with chronic shoulder pain due to rotator cuff tendinopathy. Patients will be randomly assigned to one of the two intervention groups. Clinical evaluations will include pain assessment using the Numeric Rating Scale (NRS), functional assessment using the Shoulder Pain and Disability Index (SPADI), and quality of life assessment using the Short Form-36 (SF-36). In addition, shoulder range of motion will be measured goniometrically, muscle thickness of the supraspinatus and infraspinatus will be evaluated by ultrasonography, and shoulder muscle strength will be assessed using an isokinetic dynamometer. Assessments will be performed at baseline, 24 hours, 1 month, and 3 months after the intervention. The results of this study are expected to provide evidence regarding the optimal approach for PRF treatment of the suprascapular nerve in patients with chronic shoulder pain.",[28,29],"Chronic Shoulder Pain","Rotator Cuff Tendinopathy",[31,32,28,29,33,34,35],"Suprascapular Nerve","Pulsed Radiofrequency","Isokinetic Muscle Strength","Ultrasound Measurement","Shoulder Function","RECRUITING","2026-06-26",{"date":39,"type":40},"2026-06-30","ACTUAL",{"date":42,"type":40},"2026-05-07",{"date":44,"type":22},"2027-08-30",{"name":46,"class":47},"Ankara City Hospital Bilkent","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":23,"phases":59,"briefSummary":60,"conditions":61,"keywords":62,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":48},"100578303","clinical-benefits-and-safety-of-tropho-tend-in-the-management-of-painful-rotator-cuff-tendinopathy-100578303","NCT06809543","Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy","Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy (RCT)","Inclusion Criteria\n\n* Male and female patients ≥ 18 years of age, in good general health condition.\n* Painful Rotator Cuff Tendinopathy (RCT) since ≥ 6 weeks.\n* Pain and impaired functionality on a 0 to 10 cm-centimeter specifically designed Visual Analogue Scale (VAS) ≥ 4 cm at baseline visit.\n* Rotator Cuff Tendinopathy (RCT) diagnosis, based on clinical examination.\n* Tendon ultrasound (EUS) performed within one month of enrollment.\n* Signed written informed consent.\n\nExclusion Criteria\n\n* Treatment with any investigational product within 6 months prior to clinical investigation entry.\n* Patients with known hypersensitivity to the products (active compound and excipients) or any component or procedure used in the clinical investigation.\n* Patients with para-tendinopathy, partial\u002Ftotal rupture, previous tendon surgery.\n* Severe intercurrent illness (e.g.: uncontrolled diabetes mellitus, peripheral neuropathy, autoimmune or inflammatory condition, metabolic disorders, severe oncological conditions) that, in the opinion of the investigator, may put the patient at risk when participating in the clinical investigation or affect the patient's ability to take part in the clinical investigation .\n* Patients treated with systemic and\u002For local steroids within the last 6 months, immunosuppressive drugs within the last 3 months, repeated use of non-steroidal anti-inflammatory drugs (NSAIDs) within the last week or occasional use within 24 hours.\n* Recent history of drug and\u002For alcohol abuse (within the last 6 months).\n* Pregnant or breastfeeding women","18 Years",{"count":58,"type":22},60,[25],"This is a prospective, open label, controlled, exploratory clinical investigation aimed to evaluate the clinical benefit and safety of Tropho Tend in the conservative management of painful Rotator Cuff Tendinopathy (RCT).\n\nAll subjects will be involved in the clinical investigation for 4 months for a total of 5 visits (T0= basal visit, T1, T2, T3, T4).\n\nThe control group will be represented by patients diagnosed with rotator cuff tendinopathy treated with rehabilitation physiotherapy (standard of care).\n\nThe therapy group will be represented by patients diagnosed with rotator cuff tendinopathy treated with rehabilitation physiotherapy + TrophoTend perilesional injection (TrophoTend will be added on to current standard of care).\n\nAll the screened patients at the baseline visit (T0), after checking the inclusion\u002Fexclusion criteria, will be prospectively included in the clinical investigation, in a 1:1 randomization. Patients will be randomly assigned to the \"control group\" (N=30pts), receiving rehabilitation physiotherapy (standard of care), or to the \"therapy group\" (N=30 pts), receiving Tropho Tend as a add on therapy to the rehabilitation physiotherapy.\n\nTotal duration of Clinical Investigation will be 12 months: 2-4 months for patients screening and enrolment; 1 month of therapy administration (3 perilesional injections 2 weeks apart); 3 months of follow-up; 2-4 months for data analysis and final report\u002Fpaper elaboration.\n\nAt the baseline visit (T0), an ultrasound evaluation (EUS) has to be performed to assess tendon condition. If an EUS evaluation performed within one month from T0 is available, this will be considered acceptable. This first evaluation has to be compared with another EUS performed at the final visit to obtain a qualitative description of the ultrasound appearance of the tendon after the treatment.\n\nPatients' enrolment will take 2-4 months. Tropho Tend will be administrated at T0 (basal visit) at T1 (2 weeks) and at T2 (4 weeks) for a total duration of treatment of 1 month.\n\nFollow-up will be performed at T3 (8 weeks) and T4 (12 weeks= 3 months). End of the clinical investigation will be considered the last visit for the last enrolled patient.\n\nA 40% reduction in mean VAS scores between the \"Tropho Tend therapy group\" and the \"control group\" is considered as reflecting meaningful clinical improvement for the patient.\n\nAt the final visit, the patient has to rate his\u002Fher satisfaction with the treatment using a 5-points Likert scale, where 1=very dissatisfied, 2=dissatisfied, 3=neutral, 4=satisfied, 5=highly satisfied.",[29],[63,64,65,66,67],"Polynucleotides","PN HPT","Mastelli","Rotator cuff tendinopathy","Tendinopathy","2026-01-30",{"date":70,"type":40},"2026-02-02",{"date":72,"type":40},"2024-12-10",{"date":74,"type":22},"2026-09-30",{"name":76,"class":77},"Mastelli S.r.l","INDUSTRY",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":17,"minAge":85,"maxAge":86,"enrollmentInfo":87,"targetDuration":4,"studyType":23,"phases":89,"briefSummary":90,"conditions":91,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":48},"100622959","effect-of-adding-extracorporeal-shock-wave-therapy-to-exercises-in-rotator-cuff-tendinopathy-100622959","NCT07390396","Effect of Adding Extracorporeal Shock Wave Therapy to Exercises in Rotator Cuff Tendinopathy","Effect of Adding Extracorporeal Shock Wave Therapy to Exercises in Rotator Cuff Tendinopathy: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Medically stable individuals who consent to participate in the study.\n* Male and female participants aged between 30 and 55 years.\n* Diagnosed with rotator cuff tendinopathy, confirmed clinically and by ultrasound or MRI.\n* Duration of symptoms greater than 3 months.\n* Supraspinatus tendon thickness \\> 5.85 mm as measured by ultrasound (based on Hunter et al., 2021).\n* Able to follow the treatment plan and attend all therapy sessions.\n\nExclusion Criteria:\n\n* Massive rotator cuff tear or complete tendon rupture.\n* Adhesive capsulitis or significant limitation of passive shoulder motion.\n* History of shoulder fracture, dislocation, or surgery in the affected limb.\n* Rheumatoid arthritis, diabetes mellitus, or systemic inflammatory disease.\n* Cervical radiculopathy or neurological involvement affecting the shoulder.\n* Corticosteroid injection in the affected shoulder within the last 6 months.\n* Pregnancy or breastfeeding.\n* BMI \\> 30 kg\u002Fm² (obese individuals excluded).\n* Current malignancy, open wounds, or local infection at the treatment site.\n* Inability to tolerate shock wave therapy or perform exercise sessions.","30 Years","55 Years",{"count":88,"type":22},50,[25],"Rotator cuff tendinopathy (RCT) is one of the most common causes of shoulder pain, resulting in functional limitations and reduced quality of life. Exercise therapy is considered a first-line treatment; however, adjunct modalities such as extracorporeal shock wave therapy (ESWT) may enhance recovery. This study aims to evaluate the effect of adding ESWT to a rotator cuff and scapular stabilization exercise program in patients with rotator cuff tendinopathy.",[29,92,93,94],"Shoulder Pain","Supraspinatus Tendinopathy","Shoulder Dysfunction","2026-01-29",{"date":97,"type":40},"2026-02-05",{"date":99,"type":40},"2025-12-15",{"date":101,"type":22},"2026-05",{"name":103,"class":47},"Deraya University",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":110,"eligibilityCriteria":111,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":112,"enrollmentInfo":113,"targetDuration":4,"studyType":23,"phases":115,"briefSummary":116,"conditions":117,"keywords":118,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":5},"100555868","tight-control-for-rotator-cuff-tendinopathy-100555868","NCT06517680","Tight Control for Rotator Cuff Tendinopathy","Efficacy of Tight Treatment in Rotator Cuff Tendinopathy Rotator Cuff Tendinopathy: a Randomized Controlled Trial Versus Standard Standard Management","GREAT","Inclusion Criteria :\n\nPatient with new-onset shoulder pain related to rotator cuff tendinopathy\n\n* Age between 18 and 65\n* Shoulder pain on activity for less than 6 months with VAS≥4\u002F10 and\u002For OSS≥20\n* Pain compatible with rotator cuff tendinopathy according to the rotator cuff tendinopathy according to the BESS (British Elbow and Shoulder Society) guidelines\n\nExclusion Criteria:\n\n* Contraindication to steroid injections\n* Shoulder pain related to trauma (dislocation, fracture) or acute tendon rupture requiring short-term surgery\n* Steroid injection already performed on the shoulder studied for the current episode\n* Neurological pathology affecting the shoulder\n* Other shoulder disorders (inflammatory arthritis, frozen shoulder, glenohumeral joint instability, pain associated with acromioclavicular arthropathy)\n* Tendon calcification \\> 0.5 cm.\n* Previous shoulder surgery\n* Full-thickness tear of one tendon\n* Pregnant women","65 Years",{"count":114,"type":22},156,[25],"The main objective of the study is to determine whether tight management of patients in early rotator cuff tendinopathy would lead to better clinical improvement than standard management. In a randomized study, we propose to compare two types of management, with a tight control group having one consultation per month for the first 3 months, in order to readapt or intensify management, whereas the control group will only be seen at 3 months after inclusion. We hypothesize that this close follow-up will lead to more rapid clinical improvement and reduce the transition to chronicity and the associated costs (inclusion of a medico-economic analysis taking into account, in particular, healthcare consumption and time off work).",[29],[119],"Rotator cuff tendinopathy, tight control, injection","2026-01-13",{"date":122,"type":40},"2026-01-15",{"date":124,"type":40},"2024-11-25",{"date":126,"type":22},"2027-11-25",{"name":128,"class":47},"Nantes University Hospital",{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":133,"acronym":4,"eligibilityCriteria":134,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":135,"enrollmentInfo":136,"targetDuration":4,"studyType":23,"phases":138,"briefSummary":140,"conditions":141,"keywords":4,"overallStatus":142,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":146,"completionDateStruct":147,"leadSponsor":149,"locationsCount":4},"100617573","early-phase-1-clinical-study-on-the-safety-and-efficacy-of-tendon-stem-progenitor-cells-therapy-for-rotator-cuff-tears-100617573","NCT07320378","Clinical Study on the Safety and Efficacy of Tendon Stem Progenitor Cells Therapy for Rotator Cuff Tears","Inclusion Criteria:\n\n1. Aged between 18 and 70 years, regardless of gender;\n2. Tear size classified as small (\\\u003C 1 cm) or medium-sized (1 cm to 3 cm) according to the DeOrio and Cofield classification system;\n3. Persistent shoulder pain or functional limitations despite at least 3 months of non-surgical treatment, with indications for arthroscopic rotator cuff repair;\n4. Willing to sign the informed consent form and agree to participate in this study.\n\nExclusion Criteria:\n\n1. Tear size classified as large (3 cm to 5 cm) or massive (\\> 5 cm) according to the DeOrio and Cofield classification, or Patte grade 3 tendon retraction;\n2. Subscapularis tendon tear;\n3. Complicated with anterior, posterior, or multidirectional shoulder joint instability;\n4. Indications for repair of anterior or posterior labral injury;\n5. Intra-articular injection of hyaluronic acid or corticosteroids within 3 months prior to the planned surgery;\n6. Comorbidities that contraindicate arthroscopic shoulder surgery;\n7. Local (shoulder, abdomen, buttocks) or systemic infection, osteomyelitis, or sepsis;\n8. Diabetes mellitus, untreated thyroid disease, chronic kidney disease, or rheumatoid arthritis;\n9. Immunodeficiency;\n10. Chronic diseases involving coagulation or platelet aggregation, or severe coagulopathy;\n11. Severe cardiovascular disease;\n12. Stroke or acute cardiovascular event within 6 months prior to the planned surgery;\n13. Weight loss \\> 30 kg for any reason within 12 months, or unexplained weight loss \\> 10 kg within 12 months;\n14. Eating disorder or body dysmorphic disorder;\n15. Alcohol\u002Fdrug addiction or mental illness that may affect compliance with postoperative protocols;\n16. Pregnant or lactating women;\n17. Refusal to sign the informed consent form;\n18. Other conditions deemed inappropriate by the investigators.","70 Years",{"count":137,"type":22},107,[139],"EARLY_PHASE1","Tendon injury is one of the most common sports injuries, including local tissue degeneration at the tendon insertion site following inflammation caused by long-term joint movement, friction, or strain, as well as acute traumatic tendon tears and defects of varying degrees due to sports. It is a recognized therapeutic challenge in orthopedics and sports medicine. With the increase in people's physical activities and changes in work styles, tendon injuries have become increasingly prevalent, with at least 30 million tendon injury cases annually. Meanwhile, tendon injuries pose a significant threat to the careers of many elite athletes. Currently, clinical treatments for tendon injuries mainly remain at the stages of physical therapy, surgical suture, and transplantation. Although these treatments have certain effects, their efficacy is limited-primarily because adult tendons lack complete regenerative capacity. As a result, the quality of repaired tendons is far inferior to that of normal tendons, making them prone to tendon adhesion, poor structural and mechanical properties, and frequent re-rupture. Even autologous tendon transplantation can only achieve approximately 40% of the mechanical properties of normal tendons, accompanied by excessive scar tissue formation. Current therapeutic and tissue engineering approaches can only partially improve tendon repair quality, failing to induce complete tendon repair and regeneration. Therefore, exploring new and efficient strategies for the treatment and regeneration of tendon injuries is of great significance.\n\nIn recent years, cell therapy has brought new opportunities for improving the repair quality of soft tissues such as tendons. Tendon-derived cells are isolated and extracted from tendons. These cells not only possess stem cell characteristics similar to bone marrow mesenchymal stem cells but also highly express tendon-specific genes and proteins. Therefore, this study intends to first culture and expand tendon stem\u002Fprogenitor cells (TSPCs) to form therapeutic agents, then apply TSPC-enhanced therapy intraoperatively to patients with rotator cuff tendinopathy, and evaluate its clinical safety and efficacy.",[29],"NOT_YET_RECRUITING","2025-12-22",{"date":145,"type":40},"2026-01-06",{"date":101,"type":22},{"date":148,"type":22},"2029-01",{"name":150,"class":47},"Second Affiliated Hospital, School of Medicine, Zhejiang University",{"id":152,"slug":153,"hasResults":11,"nctId":154,"briefTitle":155,"officialTitle":156,"acronym":4,"eligibilityCriteria":157,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":4,"enrollmentInfo":158,"targetDuration":4,"studyType":23,"phases":160,"briefSummary":161,"conditions":162,"keywords":170,"overallStatus":142,"whyStopped":4,"lastUpdateSubmitDate":180,"lastUpdatePostDateStruct":181,"startDateStruct":183,"completionDateStruct":185,"leadSponsor":187,"locationsCount":48},"100605159","understanding-patient-preferences-when-deciding-on-a-voluntary-musculoskeletal-test-100605159","NCT07158892","Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test","Confirmation of Values and Preferences When Considering a Musculoskeletal Diagnostic Test: A Scenario-Based Study","Inclusion Criteria:\n\n* Adults (18+ years)\n* English literacy\n* Seeking musculoskeletal specialty care\n* Diagnosis of non-traumatic musculoskeletal condition (including but not limited to: carpal tunnel syndrome, lateral epicondylitis, osteoarthritis, trigger digit, Dupuytren's, De Quervain, or rotator cuff tendinopathy)\n\nExclusion Criteria:\n\n* Cognitive or physical impairment or severe psychiatric illness that would interfere with participation in the scenario-based discussion or completion of the survey instruments",{"count":159,"type":22},220,[25],"The goal of this clinical trial is to understand how people make decisions about imaging tests for common musculoskeletal problems (like arthritis, tendon problems, or nerve compression). The study involves adult patients attending a musculoskeletal specialty clinic.\n\nThe main questions it aims to answer are:\n\n1. Does having a structured conversation about the pros and cons of a test affect how much a person wants to have that test?\n2. Does that conversation help people feel more confident and less conflicted about their decision?\n\nResearchers will compare patients who have a values-based discussion with a researcher to those who receive brief written information about the test, to see if these approaches affect how people feel about having the test.\n\nParticipants will:\n\n* Read a brief scenario about a proposed diagnostic imaging test (like an X-ray, MRI, CT, or ultrasound).\n* Either take part in a short structured conversation or read brief information about the test.\n* Answer a short survey about their thoughts on the test.\n\nThis study does not involve actual medical testing or affect your clinical care. It is for research purposes only.",[163,164,165,166,167,168,29,169],"Non-traumatic Musculoskeletal Conditions","Carpal Tunnel Syndrome (CTS)","Lateral Epicondylitis","Osteoarthritis","Trigger Digit","Dupuytren Contracture","De Quervain Disease",[171,172,173,174,175,176,177,178,179],"Musculoskeletal disorders","Diagnostic imaging","Shared decision making","Advance care planning (ACP)","Patient preferences","Health communication","Decision conflict","Scenario-Based Study","Orthopedic care","2025-09-02",{"date":182,"type":40},"2025-09-08",{"date":184,"type":22},"2025-09-10",{"date":186,"type":22},"2026-03-01",{"name":188,"class":47},"University of Texas at Austin",{"id":190,"slug":191,"hasResults":11,"nctId":192,"briefTitle":193,"officialTitle":194,"acronym":4,"eligibilityCriteria":195,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":112,"enrollmentInfo":196,"targetDuration":4,"studyType":23,"phases":198,"briefSummary":199,"conditions":200,"keywords":201,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":207,"startDateStruct":209,"completionDateStruct":211,"leadSponsor":213,"locationsCount":48},"100570485","effects-of-tnt-on-pain-rom-and-disability-in-patients-with-rc-tendinopathy-100570485","NCT06707857","Effects of TNT on Pain, ROM and Disability in Patients With RC Tendinopathy","Effects of Tendon Neuroplastic Training on Pain, Range of Motion and Disability in Patients With Rotator Cuff Tendinopathy","Inclusion Criteria:\n\n* Have a current shoulder complaint lasting at least three months prior to the time of enrollment\n* Pain is located in the proximal lateral aspect of the upper arm (C5 dermatome)\n* Positive Hawkins-Kennedy test\n\nExclusion Criteria:\n\n* Bilateral shoulder pain\n* Less than 90 degrees of active elevation of the arm\n* Corticosteroid injection within the last six weeks\n* Radiologically verified fracture\n* Glenohumeral osteoarthritis\n* Surgery or dislocation of the affected shoulder\n* Symptomatic arthritis in the Ac joint\n* Frozen shoulder\n* Symptoms derived from the cervical spine",{"count":197,"type":22},38,[25],"EFFECTS OF TENDON NEUROPLASTIC TRAINING ON PAIN, RANGE OF MOTION AND DISABILITY IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY",[29],[202,203,204,205,206],"Rotator cuff tendiopathy","Tendon neuroplastic training","Disability","Range of motion","Pain",{"date":208,"type":40},"2024-11-27",{"date":210,"type":40},"2024-04-15",{"date":212,"type":22},"2025-01",{"name":214,"class":47},"Riphah International University",{"id":216,"slug":217,"hasResults":11,"nctId":218,"briefTitle":219,"officialTitle":220,"acronym":4,"eligibilityCriteria":221,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":112,"enrollmentInfo":222,"targetDuration":4,"studyType":23,"phases":224,"briefSummary":225,"conditions":226,"keywords":229,"overallStatus":142,"whyStopped":4,"lastUpdateSubmitDate":235,"lastUpdatePostDateStruct":236,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":242,"locationsCount":48},"100513759","comparison-of-the-effectiveness-heavy-slow-resistance-and-eccentric-training-in-rotator-cuff-tendinopathy-100513759","NCT05969652","Comparison of the Effectiveness Heavy Slow Resistance and Eccentric Training in Rotator Cuff Tendinopathy","Comparison of the Effectiveness of Supervised Heavy Slow Resistance Training and Eccentric Exercise Training in Patients With Rotator Cuff Tendinopathy: A Randomized Controlled Clinical Trial","Inclusion Criteria:\n\n* Describing subacromial pain\n* Rotator cuff tendinopathy (subacromial impingement syndrome, biceps tendinitis and rotator cuff I. and II. stage diagnosis)\n* Continuation of diagnostic symptoms for at least 30 days\n\nExclusion Criteria:\n\n* Prior shoulder surgery\n* Sign of cervical radiculopathy\n* Shoulder instability or history of upper extremity fracture\n* Full-thickness rotator cuff tear\n* Adhesive capsulitis\n* Humeroscapular periarthritis (osteoarthritis, inflammatory arthropathies, etc.)\n* Neoplasm\u002Fmalignant status\n* Other independent from shoulder problem being on regular analgesic therapy for ongoing painful conditions\n* Subacromial corticosteroids in the last 2 months having received an injection or participating in a shoulder rehabilitation program",{"count":223,"type":22},20,[25],"Rotator cuff tendinopathy, also called subbracromial impingement syndrome, is one of the most important causes of anterior shoulder pain. Although exercise training is known as an effective intervention method in the treatment of rotator cuff\u002Fsubacromial impingement problems, there is no definite consensus on which type of exercise is more effective. The aim of this study is to analyze and compare the effects of the Heavy Slow Resistance (HSR) training and eccentric exercise training on pain, function, supraspinatus tendon structure, muscle strength, range of motion, subjective perception of improvement and treatment satisfaction in individuals with subacromial shoulder pain associated with rotator cuff tendinopathy.",[29,227,228],"Subacromial Impingement Syndrome","Bicep Tendinitis",[230,231,232,233,234],"Exercise therapy","Rehabilitation","Resistance training","Shoulder pain","Subacromial impingement syndrome","2024-06-26",{"date":237,"type":40},"2024-06-27",{"date":239,"type":22},"2026-01-31",{"date":241,"type":22},"2026-12-31",{"name":243,"class":47},"Mustafa Kemal University"]